Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig.

[1]  J. Nordrehaug,et al.  Tetradecylthioacetic acid reduces stenosis development after balloon angioplasty injury of rabbit iliac arteries. , 2001, Atherosclerosis.

[2]  J. Michel,et al.  Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. , 2001, Cardiovascular Research.

[3]  L. Frøyland,et al.  Long-term retention of a novel antioxidant sulphur-substituted fatty acid analogue after local delivery in porcine coronary arteries. , 2001, Scandinavian cardiovascular journal : SCJ.

[4]  Y. Yamasaki,et al.  Inhibitory effect of TAS-301, a new synthesized constrictive remodeling regulator, on renarrowing after balloon overstretch injury of porcine coronary artery. , 2000, The Journal of pharmacology and experimental therapeutics.

[5]  H. Granger,et al.  Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. , 2000, Blood.

[6]  J. Verheijen,et al.  Angioplasty : A Study in the Atherosclerotic Yucatan Micropig Metalloproteinase Inhibition Reduces Constrictive Arterial Remodeling After Balloon , 2000 .

[7]  K. Hensley,et al.  Reactive oxygen species, cell signaling, and cell injury. , 2000, Free radical biology & medicine.

[8]  E. Flescher,et al.  Suppression of interleukin 2 biosynthesis by three modes of oxidative cellular stress: selective prevention by N-acetyl cysteine. , 2000, Cytokine.

[9]  M. Ziol,et al.  Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. , 2000, Circulation.

[10]  Y. Ohmori,et al.  Regulation of Macrophage Gene Expression by Pro- and Anti-Inflammatory Cytokines , 2000, Pathobiology.

[11]  L. Madsen,et al.  Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. , 1999, Journal of lipid research.

[12]  M. Bureau,et al.  Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.

[13]  B. Staels,et al.  Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. , 1999, Current opinion in lipidology.

[14]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[15]  U. Nannmark,et al.  Matrix metalloproteinases produced by rat IL-2-activated NK cells. , 1998, Journal of immunology.

[16]  E. Edelman.  Vessel size, antioxidants, and restenosis: never too small, not too little, but often too late. , 1998, Circulation.

[17]  B. Seed,et al.  PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.

[18]  R. Berge,et al.  Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Daida,et al.  Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. , 1997, Journal of the American College of Cardiology.

[20]  S. Nattel,et al.  Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. , 1997, The New England journal of medicine.

[21]  J. Zweier,et al.  Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. , 1997, Journal of the American College of Cardiology.

[22]  L. Madsen,et al.  Up-regulated delta 9-desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: accumulation of a delta 9-desaturated metabolite of tetradecylthioacetic acid. , 1997, Journal of lipid research.

[23]  J. Lehmann,et al.  Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.

[24]  M. Leon,et al.  Intravascular ultrasound insights into mechanisms of stenosis formation and restenosis. , 1997, Cardiology clinics.

[25]  M. Leon,et al.  Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. , 1996, Circulation.

[26]  L. Deckelbaum,et al.  Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty. , 1995, American heart journal.

[27]  R. Kuntz,et al.  The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. , 1994, Circulation.

[28]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[29]  D. Brenner,et al.  d-alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation. , 1991, The Journal of clinical investigation.

[30]  C. Wilson,et al.  Transient release of lipid peroxides after coronary artery balloon angioplasty , 1990, The Lancet.

[31]  H. Rollag,et al.  Impaired in vitro survival of monocytes from patients with HIV infection , 1990, Clinical and experimental immunology.

[32]  V. Fuster,et al.  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.

[33]  J. Bremer,et al.  Alkylthioacetic acids (3-thia fatty acids) are metabolized and excreted as shortened dicarboxylic acids in vivo. , 1990, Biochimica et biophysica acta.

[34]  H. Esterbauer,et al.  Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein , 2009 .

[35]  D. Brenner,et al.  Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? , 1989, The Journal of biological chemistry.

[36]  J. Bremer,et al.  Induction of peroxisomal beta-oxidation in 7800 C1 Morris hepatoma cells in steady state by fatty acids and fatty acid analogues. , 1989, Biochimica et biophysica acta.

[37]  C. Thorpe,et al.  The reductive half-reaction in Acyl-CoA dehydrogenase from pig kidney: studies with thiaoctanoyl-CoA and oxaoctanoyl-CoA analogues. , 1988, Biochemistry.

[38]  E. Hodgson,et al.  SPECIES, ORGAN AND CELLULAR VARIATION IN THE FLAVIN-CONTAINING MONOOXYGENASE , 1988, Drug metabolism and drug interactions.

[39]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Ooshima,et al.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Lopes-Virella,et al.  Cholesterol determination in high-density lipoproteins separated by three different methods. , 1977, Clinical chemistry.

[42]  J. Lawrence,et al.  Identification of crystals deposited in brain and kidney after xylitol administration by biochemical, histochemical, and electron diffraction methods , 1973, Journal of clinical pathology.